Linagliptin vs. Sitagliptin for Type 2 Diabetes Inpatient Glycemic Management and Cardiovascular Outcomes-Is There a Difference between DPP-4 Inhibitors?-MedSci.cn

Linagliptin vs. Sitagliptin for Type 2 Diabetes Inpatient Glycemic Management and Cardiovascular Outcomes-Is There a Difference between DPP-4 Inhibitors?

Barakat, S; Habib, HA; Chun, C; Oh, E

DIABETES, 2022; 71 ():

科室
- - 订阅+
  - 更多科室
工具
服务